1 unknown, 1 withdrawn. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Unknown 1, Withdrawn 1 |
| Phase 2 | 2 | Unknown 1, Withdrawn 1 |
Follow Cancer of Liver: new trials by email Literature Review of Cancer of Liver trials Research Report on Cancer of Liver
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial of PXS-5505 Combined With First Line Atezolizumab Plus Bevacizumab For Treating Patients With Unresectable Hepatocellular Carcinoma PXS-5505 and Atezolizumab and Bevacizumab - Hepatocellular Carcinoma, Cancer of Liver | Phase 1 / Phase 2 | Withdrawn | University of Rochester | 2022-09-20 | 2023-07-13 | |
| A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies Cannabidiol, Bortezomib, Leucovorin - Cancer of Pancreas, Cancer of Liver | Phase 1 / Phase 2 | Unknown | Leaf Vertical Inc. | 160 | 2019-01-15 | 2018-07-31 |
Liver Neoplasms (2) · Carcinoma, Hepatocellular (1) · Colonic Neoplasms (1) · Gallbladder Neoplasms (1) · Glioblastoma (1) · Multiple Myeloma (1) · Pancreatic Neoplasms (1) · Rectal Neoplasms (1)
Digestive System Diseases (2) · Digestive System Neoplasms (2) · Liver Diseases (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Glandular and Epithelial (2) · Adenocarcinoma (1) · Astrocytoma (1) · Biliary Tract Diseases (1) · Biliary Tract Neoplasms (1) · Blood Protein Disorders (1) · Carcinoma (1) · Cardiovascular Diseases (1) · Colonic Diseases (1)
Bevacizumab (2) · Bortezomib (1) · Cannabidiol (1) · Fluorouracil (1) · Gemcitabine (1) · Irinotecan (1) · Leucovorin (1) · Oxaliplatin (1) · Temozolomide (1) · atezolizumab (1)
Leaf Vertical Inc. (1) · University of Rochester (1)
United States (2)
Nabeel Badri (1) · Sarah F Katta, DO (1)